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Existing American Heart Association cardiopulmonary resuscitation (CPR) guidelines do not address the challenges of providing resuscitation in the setting of the coronavirus disease 2019 (COVID-19) global pandemic, 
wherein rescuers must continuously balance the immediate needs of the pa-
tients with their own safety. To address this gap, the American Heart Asso-
ciation, in collaboration with the American Academy of Pediatrics, American 
Association for Respiratory Care, American College of Emergency Physicians, 
The Society of Critical Care Anesthesiologists, and American Society of An-
esthesiologists, and with the support of the American Association of Critical 
Care Nurses and National Association of EMS Physicians, has compiled interim 
guidance to help rescuers treat individuals with cardiac arrest with suspected 
or confirmed COVID-19.
Over the past 2 decades, there has been a steady improvement in survival 
after cardiac arrest occurring both inside and outside the hospital.1 That success 
has relied on initiating proven resuscitation interventions such as high-quality 
chest compressions and defibrillation within seconds to minutes. The evolving 
and expanding outbreak of severe acute respiratory syndrome coronavirus 2 
infections has created important challenges to such resuscitation efforts and 
requires potential modifications of established processes and practices. The 
challenge is to ensure that patients with or without COVID-19 who experience 
cardiac arrest get the best possible chance of survival without compromising the 
safety of rescuers, who will be needed to care for future patients. Complicating 
the emergency response to both out-of-hospital and in-hospital cardiac arrest 
is that COVID-19 is highly transmissible, particularly during resuscitation, and 
carries a high morbidity and mortality.
Approximately 12% to 19% of COVID-positive patients require hospital admis-
sion, and 3% to 6% become critically ill.2–4 Hypoxemic respiratory failure secondary 
to acute respiratory distress syndrome, myocardial injury, ventricular arrhythmias, 
and shock are common among critically ill patients and predispose them to cardiac 
arrest,5–8 as do some of the proposed treatments such as hydroxychloroquine and 
azithromycin, which can prolong the QT.9 With infections currently growing expo-
nentially in the United States and internationally, the percentage of patients with 
cardiac arrests and COVID-19 is likely to increase.
Healthcare workers are already the highest-risk profession for contracting the 
disease.10 This risk is compounded by worldwide shortages of personal protec-
tive equipment (PPE). Resuscitations carry added risk to healthcare workers for 
many reasons. First, the administration of CPR involves performing numerous 
aerosol-generating procedures, including chest compressions, positive-pressure 
ventilation, and establishment of an advanced airway. During those procedures, 
viral particles can remain suspended in the air with a half-life of ≈1 hour and 
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be inhaled by those nearby.11 Second, resuscitation 
efforts require numerous providers to work in close 
proximity to one another and the patient. Finally, 
these are high-stress emergency events in which the 
immediate needs of the patient requiring resuscita-
tion may result in lapses in infection-control practices.
In arriving at this interim guidance, we reviewed 
existing American Heart Association CPR recommen-
dations in the context of the COVID-19 pandemic and 
considered the unique pathophysiology of COVID-19 
with reversal of hypoxemia as a central goal. We sought 
to balance the competing interests of providing timely 
and high-quality resuscitation to patients and simulta-
neously protecting rescuers. This statement applies to 
all adult, pediatric, and neonatal resuscitations in pa-
tients with suspected or confirmed COVID-19 infection 
unless otherwise noted. The guidance contained herein 
is based on expert opinion and needs to be adapted 
locally on the basis of current disease burden and re-
source availability.
GENERAL PRINCIPLES FOR 
RESUSCITATION IN PATIENTS WITH 
SUSPECTED AND CONFIRMED 
COVID-19 
Reduce Provider Exposure to COVID-19
Rationale
It is essential that providers protect themselves and 
their colleagues from unnecessary exposure. Exposed 
providers who contract COVID-19 further decrease the 
already strained workforce available to respond and 
have the potential to add additional strain if they be-
come critically ill.
Strategies
1. Before entering the scene, all rescuers should don 
PPE to guard against contact with both airborne 
and droplet particles. Consult individual health or 
emergency medical services (EMS) system stan-
dards because PPE recommendations may vary 
considerably on the basis of current epidemiologi-
cal data and availability.
2. Limit personnel in the room or on the scene to 
only those essential for patient care.
3. In settings with protocols in place and expertise in 
their use, consider replacing manual chest com-
pressions with mechanical CPR devices to reduce 
the number of rescuers required for adults and 
adolescents who meet the manufacturer’s height 
and weight criteria.
4. Clearly communicate COVID-19 status to any 
new providers before their arrival on the scene 
or receipt of the patient when transferring to a 
second setting.
Prioritize Oxygenation and Ventilation 
Strategies With Lower Aerosolization 
Risk
Rationale 
Although the procedure of intubation carries a high risk 
of aerosolization, if the patient is intubated with a cuffed 
endotracheal tube and connected to a ventilator with a 
high-efficiency particulate air (HEPA) filter in the path of 
exhaled gas and an inline suction catheter, the resulting 
closed circuit carries a lower risk of aerosolization than 
any other form of positive-pressure ventilation.12
Strategies
5. Attach a HEPA filter securely, if available, to any 
manual or mechanical ventilation device in the 
path of exhaled gas before administering any 
breaths.
6. After healthcare providers assess the rhythm and 
defibrillate any ventricular arrhythmias, patients in 
cardiac arrest should be intubated with a cuffed 
tube at the earliest feasible opportunity. Connect 
the endotracheal tube to a ventilator with a HEPA 
filter when available.
7. Minimize the likelihood of failed intubation 
attempts by the following:
a. Assigning the provider and approach with 
the best chance of first-pass success to 
intubate
b. Pausing chest compressions to intubate
8. Video laryngoscopy may reduce intubator expo-
sure to aerosolized particles and should be con-
sidered if available.
9. Before intubation, use a bag-mask device (or T 
piece in neonates) with a HEPA filter and a tight 
seal, or, for adults, consider passive oxygenation 
with a nonrebreathing face mask covered by a 
surgical mask.
10. If intubation is delayed, consider manual ven-
tilation with a supraglottic airway or bag-mask 
device with a HEPA filter.
11. Once on a closed circuit, minimize disconnections 
to reduce aerosolization.
Consider the Appropriateness of Starting 
and Continuing Resuscitation
Rationale
• CPR is a high-intensity team effort that diverts res-
cuer attention away from other patients.13 In the 
context of COVID-19, the risk to the clinical team 
is increased and resources can be profoundly more 
limited, particularly in regions that are experiencing 
a high burden of disease. Although the outcomes 
for cardiac arrest in COVID-19 are still unknown, 
the mortality for critically ill patients with COVID-19 
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is high and rises with increasing age and comor-
bidities, particularly cardiovascular disease.2,5–8 
Therefore, it is reasonable to consider age, comor-
bidities, and severity of illness in determining the 
appropriateness of resuscitation and to balance the 
likelihood of success against the risk to rescuers and 
patients from whom resources are being diverted.14
Strategies
12. Address goals of care with patients with COVID-
19 (or proxy) in anticipation of the potential need 
for increased levels of care.
13. Healthcare systems and EMS agencies should 
institute policies to guide frontline providers in 
determining the appropriateness of starting and 
terminating CPR for patients with COVID-19, tak-
ing into account patient risk factors to estimate 
the likelihood of survival. Risk stratification and 
policies should be communicated to patients (or 
proxy) during discussions of goals of care.
14. There are insufficient data to support extracorpo-
real CPR for patients with COVID-19.
ALGORITHMS WITH KEY CHANGES
Figures 2 through 6 reflect COVID-19–specific updates 
to the current basic life support, advanced cardiovascu-
lar life support, pediatric basic life support, and pediat-
ric cardiac arrest algorithms and are meant to replace 
the standard algorithms in patients with suspected or 
confirmed COVID-19 disease. In COVID-19–negative 
patients or when COVID-19 is not suspected, cardiac 
arrest resuscitations should proceed according to the 
standard algorithms. New boxes specific to COVID-19 
are in yellow, and new guidance specific to COVID-19 
is bolded and underlined.
SITUATION- AND SETTING-SPECIFIC 
CONSIDERATIONS
Out-of-Hospital Cardiac Arrest
Below are specific considerations for cardiac arrest in 
individuals with suspected or confirmed COVID-19 
occurring outside of the hospital. Depending on local 
Figure 1. Summary of adjustments to cardiopulmonary resuscitation (CPR) algorithms in patients with suspected or confirmed coronavirus disease 
2019 (COVID-19).
HEPA indicates high-efficiency particulate air; and PPE, personal protective equipment.
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prevalence and evidence of community spread, COV-
ID-19 may be suspected in some out-of-hospital cardiac 
arrests.
Lay Rescuers
Bystander CPR has consistently been shown to improve 
the likelihood of survival from out-of-hospital cardiac 
arrest, which decreases with every minute that CPR and 
defibrillation are delayed.15–17 Rescuers in the community 
are unlikely to have access to adequate PPE and therefore 
may be at increased risk of exposure to COVID-19 during 
CPR compared with healthcare providers with adequate 
PPE. Rescuers with increasing age and the presence of 
Figure 2. Basic life support healthcare provider adult cardiac arrest algorithm for patients with suspected or confirmed coronavirus disease 2019 
(COVID-19).
AED indicates automated external defibrillator; ALS, advanced life support; CPR, cardiopulmonary resuscitation; and PPE, personal protective equipment.
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comorbid conditions such as heart disease, diabetes mel-
litus, hypertension, and chronic lung disease4 are at in-
creased risk of becoming critically ill if infected with severe 
acute respiratory syndrome coronavirus 2. However, when 
the cardiac arrest occurs at home (as has been reported in 
70% of out-of-hospital cardiac arrests17 before the recent 
widespread shelter-at-home ordinances), lay rescuers are 
likely to have already been exposed to COVID-19.
Figure 3. Advanced cardiac life support cardiac arrest algorithm for patients with suspected or confirmed coronavirus disease 2019 (COVID-19).
CPR indicates cardiopulmonary resuscitation; ET, endotracheal; PEA, pulseless electric activity; Petco2, end-tidal carbon dioxide; PPE, personal protective equipment; 
pVT, pulseless ventricular tachycardia; ROSC, return of spontaneous circulation; and VF, ventricular fibrillation.
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Chest Compressions
• For adults: Lay rescuers should perform at least 
hands-only CPR after recognition of a cardiac 
arrest event, if willing and able, especially if they 
are household members who have been exposed 
to the patient at home. A face mask or cloth cov-
ering the mouth and nose of the rescuer and/or 
patient may reduce the risk of transmission to a 
nonhousehold bystander.
• For children: Lay rescuers should perform chest 
compressions and consider mouth-to-mouth 
ventilation, if willing and able, given the higher 
incidence of respiratory arrest in children,17 espe-
cially if they are household members who have 
been exposed to the patient at home. A face 
mask or cloth covering the mouth and nose of 
the rescuer and/or patient may reduce the risk 
of transmission to a nonhousehold bystander if 
Figure 4. Basic life support healthcare provider pediatric cardiac arrest algorithm for the single rescuer for patients with suspected or confirmed 
coronavirus disease 2019 (COVID-19).
AED indicates automated external defibrillator; ALS, advanced life support; CPR, cardiopulmonary resuscitation; and PPE, personal protective equipment.
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unable or unwilling to perform mouth-to-mouth 
ventilation.
Public-Access Defibrillation
• Because defibrillation is not expected to be a highly 
aerosolizing procedure, lay rescuers should use an 
automated external defibrillator, if available, to assess 
and treat patients with out-of-hospital cardiac arrest.
EMS
Transport
• Family members and other contacts of patients 
with suspected or confirmed COVID-19 should not 
ride in the transport vehicle.
• If return of spontaneous circulation has not been 
achieved after appropriate resuscitation efforts in 
Figure 5. Basic life support healthcare provider pediatric cardiac arrest algorithm for ≥2 rescuers for patients with suspected or confirmed coronavi-
rus disease 2019 (COVID-19).
AED indicates automated external defibrillator; ALS, advanced life support; CPR, cardiopulmonary resuscitation; and PPE, personal protective equipment.
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Figure 6. Pediatric cardiac arrest algorithm for patients with suspected or confirmed coronavirus disease 2019 (COVID-19).
CPR indicates cardiopulmonary resuscitation; ET, endotracheal; PEA, pulseless electric activity; PPE, personal protective equipment; pVT, pulseless ventricular tachy-
cardia; ROSC, return of spontaneous circulation; and VF, ventricular fibrillation.
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the field, consider not transferring to hospital given 
the low likelihood of survival for the patient,17 bal-
anced against the added risk of additional expo-
sure to prehospital and hospital providers.
In-Hospital Cardiac Arrest
Below are specific considerations for patients with 
suspected or confirmed COVID-19 in the hospital 
setting. These interim guidelines do not apply to 
patients who are known to be COVID-19 negative. 
Those patients should receive standard basic and ad-
vanced life support. However, it may be reasonable 
to reduce the number of personnel in the room for 
all resuscitations during the pandemic for social dis-
tancing purposes.
Prearrest
• Address advanced care directives and goals of 
care with all patients with suspected or confirmed 
COVID-19 (or proxy) on hospital arrival and with 
any significant change in clinical status such as an 
increase in level of care.
• Closely monitor for signs and symptoms of clini-
cal deterioration to minimize the need for emer-
gency intubations that put patients and providers 
at higher risk.
• If the patient is at risk for cardiac arrest, consider 
proactively moving the patient to a negative-pres-
sure room/unit, if available, to minimize risk of 
exposure to rescuers during a resuscitation.
• Close the door when possible to prevent airborne 
contamination of adjacent indoor space.
Intubated Patients at the Time of Cardiac Arrest
• Consider leaving the patient on a mechanical ven-
tilator with a HEPA filter to maintain a closed cir-
cuit and to reduce aerosolization.
• Adjust the ventilator settings to allow asynchronous 
ventilation (time chest compressions with ventilation 
in newborns). Consider the following suggestions:
– Increase the Fio2 to 1.0.
– Use either pressure or volume control venti-
lation and limit pressure or tidal volume to 
generate adequate chest rise (4-6 mL/kg ideal 
body weight is often targeted [6mL/kg for 
adults]).
– Adjust the trigger to “off” to prevent the 
ventilator from autotriggering with chest 
compressions and possibly prevent hyperven-
tilation and air trapping.
– Adjust respiratory rate to 10 breaths/min for 
adults and pediatrics and 30 breaths/min for 
neonates.
– Assess the need to adjust the positive end-
expiratory pressure level to balance lung vol-
umes and venous return.
– Adjust alarms to deliver full breaths with 
asynchronous chest compressions.
– Ensure endotracheal tube/tracheostomy 
and ventilator circuit security to prevent 
unplanned extubation.
• If return of spontaneous circulation is achieved, set 
ventilator settings as appropriate to patients’ clini-
cal condition.
Prone Patients at the Time of Arrest
• For patients with suspected or confirmed COVID-
19 who are in a prone position without an 
advanced airway, attempt to place in the supine 
position for continued resuscitation.
• Although the effectiveness of CPR in the prone 
position is not completely known, for those 
patients who are in the prone position with an 
advanced airway, it may be reasonable to avoid 
turning the patient to the supine position, unless 
able to do so without risk of equipment disconnec-
tions and aerosolization. If unable to safely tran-
sition the patient to a supine position, place the 
defibrillator pads in the anterior-posterior position 
and provide CPR with the patient remaining prone 
with hands in the standard position over the T7/10 
vertebral bodies.18
Postarrest Patients
• Consult local infection control practices concern-
ing transport after resuscitation.
Maternal and Neonatal Considerations
Neonatal Resuscitation
Every newly born baby should have a skilled attendant 
prepared to resuscitate regardless of COVID-19 status. 
Although it remains unclear if newly born babies are 
infected or likely to be infectious when mothers have 
suspected or confirmed COVID-19, providers should 
don appropriate PPE. The mother is a potential source 
of aerosolization for the neonatal team.
• Initial steps: Routine neonatal care and the initial 
steps of neonatal resuscitation are unlikely to be 
aerosol generating; they include drying, tactile 
stimulation, placement into a plastic bag or wrap, 
assessment of heart rate, and placement of pulse 
oximetry and electrocardiographic leads.
• Suction: Suction of the airway after delivery should 
not be performed routinely for clear or meconium-
stained amniotic fluid. Suctioning is an aerosol-
generating procedure and is not indicated for 
uncomplicated deliveries.
• Endotracheal medications: Endotracheal instilla-
tion of medications such as surfactant or epineph-
rine is an aerosol-generating procedure, especially 
via an uncuffed tube. Intravenous delivery of epi-
nephrine via a low-lying umbilical venous catheter 
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is the preferred route of administration during 
neonatal resuscitation.
• Closed incubators: Closed incubator transfer and 
care (with appropriate distancing) should be used 
for neonatal intensive care patients when possible 
but do not protect against aerosolization of virus.
Maternal Cardiac Arrest
The tenets of maternal cardiac arrest are unchanged for 
women with suspected or confirmed COVID-19.
• The cardiopulmonary physiological changes of 
pregnancy may increase the risk of acute decom-
pensation in critically ill pregnant patients with 
COVID-19.
• Preparation for perimortem delivery, to occur after 
4 minutes of resuscitation, should be initiated early 
in the resuscitation algorithm to allow the assem-
bly of obstetric and neonatal teams with PPE even 
if return of spontaneous circulation is achieved 
and perimortem delivery is not required.
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